醋酸乌利司他治疗播散性腹膜平滑肌瘤病
一例23岁女性因腹痛就诊,影像学发现腹盆腔无数结节,活检符合播散性腹膜平滑肌瘤病。醋酸亮丙瑞林治疗有效但因血管舒缩症状停用,改为周期性醋酸乌利司他,2年内完成五个3个月疗程,症状和影像学反应极好。作者认为醋酸乌利司他可能是播散性腹膜平滑肌瘤病的一种有效新型治疗选择。
要点
- 播散性腹膜平滑肌瘤病为激素敏感性罕见病,手术困难,激素抑制是主要治疗。
- 本例醋酸亮丙瑞林治疗有效但因血管舒缩症状停用。
- 改用周期性醋酸乌利司他后症状和影像学反应极好。
核心结论
- 作者认为醋酸乌利司他可能是管理播散性腹膜平滑肌瘤病的一种有效新型治疗选择。
研究设计与样本
- 个案报告:一例23岁女性,因腹痛就诊,影像学发现腹盆腔无数结节,活检符合播散性腹膜平滑肌瘤病。
主要发现
- 醋酸亮丙瑞林治疗获得满意结果,但因血管舒缩症状而停用。
- 改用周期性醋酸乌利司他后,过去2年内患者完成五个3个月疗程,症状和影像学反应极好。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disseminated peritoneal leiomyomatosis is a rare condition manifesting as hormone-sensitive soft tissue nodules lining the peritoneal cavity. Given the extensiveness of this disease, surgical management is challenging, making hormonal suppression the primary treatment. CASE: A 23-year-old woman presenting with abdominal pain was found to have innumerable abdominopelvic nodules on imaging. Biopsy of these lesions was consistent with disseminated peritoneal leiomyomatosis. Treatment using leuprolide acetate led to satisfactory results but was discontinued owing to vasomotor symptoms. Treatment was changed to cyclic ulipristal acetate, a selective progesterone receptor modulator. Over the past 2 years, the patient has completed five 3-month courses of ulipristal acetate with excellent symptomatic and radiologic response. CONCLUSION: The use of ulipristal acetate may be an effective, novel therapeutic option for the management of disseminated peritoneal leiomyomatosis.
引用
- Benlolo S, Papillon-Smith J, Murji A, et al. Ulipristal Acetate for Disseminated Peritoneal Leiomyomatosis. Obstet Gynecol. 2019. PMID: 30741799. doi:10.1097/AOG.0000000000003112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。